A comparative study on the hepatoprotective action of bear bile and coptidis rhizoma aqueous extract on experimental liver fibrosis in rats

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Wang, Ning ^a   Feng, Yibin ^a   Cheung, Fan ^a   Chow, Oi Yee ^a   Wang, Xuanbin ^a,c   Su, Weiwei ^b   Tong, Yao ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Alternative; Bear bile; Comparative study; Coptidis rhizoma; Liver fibrosis

Indexed keywords

BERBERINE; BILE EXTRACT; COPTIS RHIZOME EXTRACT; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEAR BILE; BILE; BILE DUCT LIGATION; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; COPTIS; DRUG MECHANISM; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER FIBROSIS; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; QUALITY CONTROL;

EID: 84870055764     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-239     Document Type: Article

References (28)

1. Xiong HJ, Tu Q, Chen YZ. The Moon Bear (Video) http://v.youku.com/v_show/id_XMzU4MDI1ODA4.html. Visiting time: March 3, 2012.
2. Feng Y, Siu K, Wang N, Ng KM, Tsao SW, Nagamatsu T, Tong Y. Bear bile:dilemma of traditional medicinal use and animal protection. J Ethnobiol Ethnomed 2009, 5:2. 10.1186/1746-4269-5-2, 2630947, 19138420.
3. Wang N, Feng Y, Xie T, Su W, Zhu M, Chow OY, Zhang Y, Ng KM, Leung CH, Tong Y. Chemical and biological analysis of active free and conjugated bile acids in animal bile using HPLC-ELSD and MTT methods. Exp Ther Med 2011, 2:125-130. 3440638, 22977479.
4. Feng Y, Cheung KF, Wang N, Liu P, Nagamatsu T, Tong Y. Chinese medicines as a resource for liver fibrosis treatment. Chin Med 2009, 4:16. 10.1186/1749-8546-4-16, 3224967, 19695098.
5. Ye X, Feng Y, Tong Y, Ng KM, Tsao S, Lau GK, Sze C, Zhang Y, Tang J, Shen J, Kobayashi S. Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced acute liver hepatotoxicity in rats. J Ethnopharmacol 2009, 124:130-136. 10.1016/j.jep.2009.04.003, 19536921.
6. Feng Y, Wang N, Ye X, Li H, Feng Y, Cheung F, Nagamatsu T. Hepatoprotective effect and its possible mechanism of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced chronic liver hepatotoxicity in rats. J Ethnopharmacol 2011, 138:683-90. 10.1016/j.jep.2011.09.032, 21963555.
7. Feng Y, Siu KY, Ye X, Wang N, Yuen MF, Leung CH, Tong Y, Kobayashi S. Hepatoprotective effects of berberine on carbon tetrachloride-induced acute hepatotoxicity in rats. Chin Med 2010, 5:33. 10.1186/1749-8546-5-33, 2949732, 20849653.
8. Wang N, Feng Y, Lau EP, Tsang C, Ching Y, Man K, Tong Y, Nagamatsu T, Su W, Tsao S. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther 2010, 9:354-364. 10.1177/1534735410379121, 21106616.
9. Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, Tsao SW. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010, 111:1426-1436. 10.1002/jcb.22869, 20830746.
10. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003, 38:38-53.
11. Wells RG. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol 2005, 39:158-161.
12. Li J, Niu JZ, Wang JF, Li Y, Tao XH. Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model. World J Gastroenterol 2005, 11:6483-6488.
13. Maataoui A, Qian J, Vossoughi D, Khan MF, Oppermann E, Bechstein WO, Vogl TJ. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model. Eur Radiol 2005, 15:127-133. 10.1007/s00330-004-2517-8, 15580507.
14. Gabriel GG. A bitter medicine, the use of bear bile in China. Proceddings of the Third International Symposium of the Trade in Bear Parts 1999, 116-120. Seoul: TRAFFIC East Asia, Williamson DF, Phipps MJ.
15. Still J. Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complement Ther Med 2003, 11:118-122. 10.1016/S0965-2299(03)00055-4, 12801499.
16. Gu XC, Li MD, Chang JQ, Cui GZ. Comparison between pharmacologic action of rabbit bile and bear bile. Zhongguo Zhong Yao Za Zhi 1994, 19:556-558.
17. Li YW, Zhu XY, But PP, Yueng HW. Ethnopharmacology of bear gall bladder: I. J Ethnopharmacol 1995, 47:23-31.
18. Appiah SS, Bremner P, Heinrich M, Kokubun T, Simmonds MSJ, Bell C. Herbal alternatives to bear bile: effects of Scutellaria baicalensis Georgi on IL-6 promoter and CYP3A4 activities. Focus Altern Complement Ther 2006, 11:03.
19. Boatright JH, Nickerson JM, Moring AG, Pardue MT. Bile acids in treatment of ocular disease. J Ocul Biol Dis Infor 2009, 2:149-159. 10.1007/s12177-009-9030-x, 2798994,2798994, 20046852.
20. Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2002, 1:CD000551.
21. Rohrer U, Kunz EM, Lenkeit K, Schaffner W, Meyer J. Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria. Schweiz Monatsschr Zahnmed 2007, 117:1126-1131.
22. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, Shin HJ, Kim WS, Kim JB. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 2009, 296:E955-E964. 10.1152/ajpendo.90599.2008, 19208854.
23. Zhang DM, He ZW, Liu XD, Li Y, Xie L, Wang GJ, Liu L. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier. J Pharmacol Pharmacother 2007, 59:1733-1738.
24. Zhou J, Zhou S, Tang J, Zhang K, Guang L, Huang Y, Xu Y, Ying Y, Zhang L, Li D. Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 2009, 606:262-268. 10.1016/j.ejphar.2008.12.056, 19374872.
25. Zhao W, Xue R, Zhou ZX, Kong WJ, Jiang JD. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. Biomed Pharmacother 2008, 62:730-731. 10.1016/j.biopha.2008.01.007, 18337056.
26. Zhang BJ, Xu D, Guo Y, Ping J, Chen LB, Wang H. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin Exp Pharmacol Physiol 2008, 35:303-309. 10.1111/j.1440-1681.2007.04819.x, 17973934.
27. Sun X, Zhang X, Hu H, Lu Y, Chen J, Yasuda K, Wang H. Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis. Biol Pharm Bull 2009, 32:1533-1537. 10.1248/bpb.32.1533, 19721228.
28. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H. Trends in oxidative aging theories. Free Radic Biol Med 2007, 43:477-503. 10.1016/j.freeradbiomed.2007.03.034, 17640558.